Clinical Trial Update: Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating irradiation-based myeloablative conditioning followed by regulatory T cell and conventional T cell immunotherapy as HSCT condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Lymphoid Leukemia
• Lymphoma
• Multiple Myeloma
• Myeloproliferative Disorders
• Other Hematologic Malignant Neoplasms

Snippet

Sponsor: University Of Perugia | Conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia | Phase 2 | Status: UNKNOWN